Biomarkers in heart failure: the importance of inconvenient details - Wikidata - wikimedia - TriplyDB

Biomarkers in heart failure: the importance of inconvenient details

Biomarkers in heart failure: the importance of inconvenient details

http://www.wikidata.org/entity/Q28067646

about

N-terminal-pro brain natriuretic peptides in dogs and cats: A technical and clinical review.Digital Twins in Health Care: Ethical Implications of an Emerging Engineering Paradigm.

P2860

Q46438819-08693648-3F17-4ECA-8D7B-8C437BC81037 Q50300683-BAB5F3FF-205F-436B-A3EE-B48A520B6853

P2860

Biomarkers in heart failure: the importance of inconvenient details

http://www.wikidata.org/entity/Q28067646

description

2016 nî lūn-bûn

@nan

2016 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի մարտին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Biomarkers in heart failure: the importance of inconvenient details

@ast

Biomarkers in heart failure: the importance of inconvenient details

@en

Biomarkers in heart failure: the importance of inconvenient details

@nl

type

label

Biomarkers in heart failure: the importance of inconvenient details

@ast

Biomarkers in heart failure: the importance of inconvenient details

@en

Biomarkers in heart failure: the importance of inconvenient details

@nl

prefLabel

Biomarkers in heart failure: the importance of inconvenient details

@ast

Biomarkers in heart failure: the importance of inconvenient details

@en

Biomarkers in heart failure: the importance of inconvenient details

@nl

P1433

Q28067646-9914C153-1CDB-421C-AB64-095C06BCFBCB

P1476

Q28067646-CBB62255-1E4B-4FC9-BB69-520BD4654880

P2093

Q28067646-3B178150-8E0C-438B-974A-08929864431F

Q28067646-CC495769-3E75-4C5F-B091-CA6EE163D81C

P2860

Q28067646-0705DA79-3C35-42E2-BAE3-D18BFFA48C56

Q28067646-0951C77A-8B2D-4F38-B01B-9EEAF6767215

Q28067646-1735EBDA-EF1D-491C-BEE4-94330653BC04

Q28067646-27E58993-27DB-4CC8-81BD-39FC6CFDC355

Q28067646-2AB9B701-F0E0-49E4-8C6C-6384C119A3D8

Q28067646-2C85B697-EB7E-481E-BEA4-F3DF9459F653

Q28067646-3914F4A7-F590-4C13-8440-4DB354DBE6F4

Q28067646-3E1535C4-45FF-4EA3-BD44-6E1202779F37

Q28067646-490EC5DE-09C4-4BE4-923A-58B0F2D9F4D8

Q28067646-50BB153C-C56D-4A45-8103-031069475343

P304

Q28067646-9C4C2100-A698-414F-854C-F57A560FEE3F

P31

Q28067646-83DB71FA-1B9D-4FB2-BE18-B4E85805BAE1

P356

Q28067646-5E90B056-F99E-4003-B025-5DD962FF6952

P407

Q28067646-A3AE889F-B42D-4DA4-B71C-6F31D6FC20D6

P433

Q28067646-6884C9D1-9175-42B1-90EF-30EA6DE8DA50

P478

Q28067646-ECE6097B-145C-43EF-BF9B-793A8694DA73

P577

Q28067646-C9A964D6-F939-49E1-A0BC-0202A69E11DE

P698

Q28067646-2A739CF9-DC3D-4287-8A7D-CF484CFED7F2

P921

Q28067646-5847F872-A966-48F2-8F55-1012E695FF3E

Q28067646-C06AC7C0-9DFD-4C4E-9391-E88AD9FCBB1F

P932

Q28067646-9F612997-B925-4A72-9114-453C3DCF54D1

P356

P1433

ESC heart failure

P1476

Biomarkers in heart failure: the importance of inconvenient details

@en

P2093

Allan S. Jaffe

http://www.w3.org/2001/XMLSchema#string

Wayne L. Miller

http://www.w3.org/2001/XMLSchema#string

P2860

Use of natriuretic peptides to guide and monitor heart failure therapy.

Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction

Aldosterone receptor antagonists: effective but often forgotten.

The existence of publication bias and risk factors for its occurrence.

Biomarkers of cardiovascular disease: molecular basis and practical considerations.

Plasma brain natriuretic peptide concentration: impact of age and gender.

Serial measurements of midregion proANP and copeptin in ambulatory patients with heart failure: incremental prognostic value of novel biomarkers in heart failure.

Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population

Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results.

Publication bias against negative results from clinical trials: three of the seven deadly sins.

P304

3-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/EHF2.12071

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27774262

http://www.w3.org/2001/XMLSchema#string

P921

P932

5063139

http://www.w3.org/2001/XMLSchema#string